# Cencora, Inc. (COR) stock: price and valuation

URL: https://funkfolio.com/stock/COR

> Cencora, Inc. (COR) trades at $352.96, is worth $67.35B, is priced at 19.7× earnings and scores 61/100. Valuation, financials and signals.

---

## Cencora, Inc. (COR)

Cencora, Inc. (COR) is a healthcare company (medical distribution) based in the United States. The share price is $352.96, down 1.12% on the day, which values the company at $67.35B. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $352.96 −1.12% today
- **Market value:** $67.35B
- **P/E ratio:** 19.7× last 12 months
- **Forward P/E:** 16.3×
- **Dividend yield:** 0.67%
- **Funk Score:** 61/100
- **Against its own history:** Well above its usual price usual price $189.89
- **200-week average:** $256.02 38% above

Figures as of 17 Nov 2026, 17:37 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Cencora, Inc. in more detail

COR trades at 19.7× its last twelve months' earnings, 16.3× next year's expected earnings, 0.2× sales. Measured against its own history, the price is 86% above what its usual multiples would imply ($189.89) — well above its usual price. It sits 38% above its 200-week average of $256.02.

Over the last five fiscal years Cencora, Inc. has compounded revenue 11.1% a year, free cash flow 11.8% a year. Its Funk Score is 61 out of 100 (financial strength 7.3, profitability 5.0, growth 7.0, value 5.2, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling.

3 of the superinvestors tracked here hold COR, including Steve Cohen (0.3% of the portfolio), Ken Griffin (0.2% of the portfolio), Israel Englander (0.2% of the portfolio).

### Superinvestors holding COR

3 of the investors tracked here report a position in their latest 13F filing.

- [Steve Cohen Point72 Asset Management](https://funkfolio.com/gurus/steve-cohen) 0.26% of portfolio · $171.1M · added · Q2 2026
- [Ken Griffin Citadel Advisors](https://funkfolio.com/gurus/ken-griffin) 0.22% of portfolio · $386.7M · added · Q2 2026
- [Israel Englander Millennium Management](https://funkfolio.com/gurus/israel-englander) 0.18% of portfolio · $269M · added · Q2 2026

### Health Care companies of similar size

- [Cigna Group CI](https://funkfolio.com/stock/CI)
- [Takeda Pharmaceutical TAK](https://funkfolio.com/stock/TAK)
- [Boston Scientific BSX](https://funkfolio.com/stock/BSX)
- [Cardinal Health CAH](https://funkfolio.com/stock/CAH)
- [argenx ARGX](https://funkfolio.com/stock/ARGX)
- [Edwards Lifesciences EW](https://funkfolio.com/stock/EW)
- [Becton, Dickinson BDX](https://funkfolio.com/stock/BDX)
- [IDEXX Laboratories IDXX](https://funkfolio.com/stock/IDXX)
- [Medline MDLN](https://funkfolio.com/stock/MDLN)
- [Humana HUM](https://funkfolio.com/stock/HUM)
- [Agilent Technologies A](https://funkfolio.com/stock/A)
- [Teva Pharmaceutical Industries TEVA](https://funkfolio.com/stock/TEVA)

Side by side: [COR vs TAK (Cencora, Inc. vs Takeda Pharmaceutical)](https://funkfolio.com/compare/cor-vs-tak) [COR vs BSX (Cencora, Inc. vs Boston Scientific)](https://funkfolio.com/compare/bsx-vs-cor) [COR vs CAH (Cencora, Inc. vs Cardinal Health)](https://funkfolio.com/compare/cah-vs-cor) [COR vs ARGX (Cencora, Inc. vs argenx)](https://funkfolio.com/compare/argx-vs-cor) [COR vs EW (Cencora, Inc. vs Edwards Lifesciences)](https://funkfolio.com/compare/cor-vs-ew)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Cencora, Inc. (COR): questions and answers

**What is COR's P/E ratio?**

Cencora, Inc. trades at 19.7× its last twelve months' earnings and 16.3× next year's expected earnings. At its fiscal year-ends over the past 16 years the P/E ranged from 12.2× to 66.6×, with a median of 19.3×.

**What is COR's PEG ratio?**

Cencora, Inc.'s PEG ratio is 0.79 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Cencora, Inc.'s market cap?**

Cencora, Inc. is valued at $67.35B at a share price of $352.96.

**Is COR overvalued or undervalued?**

Against its own history, COR is well above its usual price: the price is 86% above the $189.89 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is COR above its 200-week moving average?**

Yes. COR is 37.9% above its 200-week average of $256.02. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Cencora, Inc. growing?**

Over the last five fiscal years Cencora, Inc.'s revenue grew 11.1% a year; over ten years revenue grew 9.0% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Cencora, Inc. (COR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COR

Underlying data: Yahoo Finance; company filings with the SEC.
